Among 77 RET pathogenic variant carriers (52 [67.5%] of whom underwent Sanger sequencing as part of the MyCode Genome Screening and Counseling Program to confirm the variant), 10 were found to have medullary thyroid cancer. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.